Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1
Hits:
Institution:药学院
Title of Paper:Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1
Journal:Expert Opinion on Therapeutic Patents
First Author:程锡强
All the Authors:展鹏,刘新泳
Document Code:A9472303DA3F4813AA4416BF776CD379
Volume:27
Issue:11
Page Number:1277
Translation or Not:No
Date of Publication:2017-06
Release Time:2019-10-25
Prev One:Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles
Next One:Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-based molecular hybridization